213 related articles for article (PubMed ID: 23398414)
1. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.
Kim M; Li M; Intong LR; Tran K; Melbourne W; Marucci D; Bucci J; de Souza P; Mallesara G; Murrell DF
Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414
[No Abstract] [Full Text] [Related]
2. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Reimer A; Lu S; He Y; Bruckner-Tuderman L; Technau-Hafsi K; Meiss F; Has C; von Bubnoff D
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134
[No Abstract] [Full Text] [Related]
3. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
[No Abstract] [Full Text] [Related]
4. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
5. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma and a squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Chorny JA; Shroyer KR; Golitz LE
Arch Dermatol; 1993 Sep; 129(9):1212. PubMed ID: 8363416
[No Abstract] [Full Text] [Related]
7. Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.
Piccerillo A; El Hachem M; De Vito R; De Luca EV; Peris K
JAMA Dermatol; 2020 Jun; 156(6):708-710. PubMed ID: 32320041
[No Abstract] [Full Text] [Related]
8. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
9. Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.
Medek K; Koelblinger P; Koller J; Diem A; Ude-Schoder K; Bauer JW; Laimer M
J Dtsch Dermatol Ges; 2019 Apr; 17(4):448-450. PubMed ID: 30821421
[No Abstract] [Full Text] [Related]
10. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
12. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
13. Large metastasizing squamous cell carcinoma in epidermolysis bullosa dystrophica Hallopeau-Siemens.
Süss A; Sticherling M; Volz A; Frank R; Rudolph KD; Simon JC
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):539-41. PubMed ID: 17373986
[No Abstract] [Full Text] [Related]
14. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
Ciurescu D; Condruz S; Irimie M
Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.
Tomita Y; Sato-Matsumura KC; Sawamura D; Matsumura T; Shimizu H
Acta Derm Venereol; 2003; 83(3):225-6. PubMed ID: 12816163
[No Abstract] [Full Text] [Related]
16. Successful combination therapy of a locally advanced squamous cell carcinoma of the skin with cetuximab and γ-irradiation.
Göppner D; Nekwasil S; Franke I; Gollnick H; Leverkus M
J Dtsch Dermatol Ges; 2010 Oct; 8(10):826-8. PubMed ID: 20731754
[No Abstract] [Full Text] [Related]
17. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
[No Abstract] [Full Text] [Related]
18. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
19. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy.
Lentz SR; Raish RJ; Orlowski EP; Marion JM
Cancer; 1990 Sep; 66(6):1276-8. PubMed ID: 2205357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]